Literature DB >> 10416513

Increased apolipoprotein B serum concentration in Alzheimer's disease.

P Caramelli1, R Nitrini, R Maranhão, A C Lourenço, M C Damasceno, C Vinagre, B Caramelli.   

Abstract

OBJECTIVE: To investigate the lipoprotein profile in a group of Alzheimer's disease (AD) patients. PATIENTS AND METHODS: Twenty-four patients with AD and 32 elderly controls were evaluated. Fasting blood samples were obtained for determination of total VLDL, HDL and LDL cholesterol, lipoprotein (a), triglycerides, apolipoprotein A1 and apolipoprotein B.
RESULTS: Significantly higher levels of apolipoprotein B were found in AD patients (P = 0.004), whereas the concentration of lipoprotein (a) and plasma lipids was not statistically different. Apo B levels were similar between AD patients with or without leukoaraiosis on CT scan.
CONCLUSION: AD patients had high serum concentration of apolipoprotein B. This finding suggests that apolipoprotein E may not be the single factor in lipid metabolism to play a role in AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416513     DOI: 10.1111/j.1600-0404.1999.tb00724.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  28 in total

1.  Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease.

Authors:  Ling Li; Dongfeng Cao; David W Garber; Helen Kim; Ken-ichiro Fukuchi
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

2.  Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.

Authors:  Navin Rauniyar; Kanagaraj Subramanian; Mathieu Lavallée-Adam; Salvador Martínez-Bartolomé; William E Balch; John R Yates
Journal:  Mol Cell Proteomics       Date:  2015-04-14       Impact factor: 5.911

3.  Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.

Authors:  K Hall; J Murrell; A Ogunniyi; M Deeg; O Baiyewu; S Gao; O Gureje; J Dickens; R Evans; V Smith-Gamble; F W Unverzagt; J Shen; H Hendrie
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

4.  Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.

Authors:  Matej Mihelčić; Goran Šimić; Mirjana Babić Leko; Nada Lavrač; Sašo Džeroski; Tomislav Šmuc
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

5.  Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study.

Authors:  G Zuliani; M Cavalieri; M Galvani; S Volpato; A Cherubini; S Bandinelli; A M Corsi; F Lauretani; J M Guralnik; R Fellin; L Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-18       Impact factor: 6.053

6.  Disease risk factors identified through shared genetic architecture and electronic medical records.

Authors:  Li Li; David J Ruau; Chirag J Patel; Susan C Weber; Rong Chen; Nicholas P Tatonetti; Joel T Dudley; Atul J Butte
Journal:  Sci Transl Med       Date:  2014-04-30       Impact factor: 17.956

7.  Identifying Neuroimaging and Proteomic Biomarkers for MCI and AD via the Elastic Net.

Authors:  Li Shen; Sungeun Kim; Yuan Qi; Mark Inlow; Shanker Swaminathan; Kwangsik Nho; Jing Wan; Shannon L Risacher; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Andrew J Saykin
Journal:  Multimodal Brain Image Anal (2011)       Date:  2011-09

8.  Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK).

Authors:  Juho Tynkkynen; Jussi A Hernesniemi; Tiina Laatikainen; Aki S Havulinna; Jouko Sundvall; Jaana Leiviskä; Perttu Salo; Veikko Salomaa
Journal:  Age (Dordr)       Date:  2016-09-23

9.  Cortisol, HDL-c, VLDL-c, and APOE Polymorphisms as Laboratorial Parameters Associated to Cognitive Impairment No Dementia (CIND) and Dementia.

Authors:  Vivian P Lara; Paulo Caramelli; Antônio L Teixeira; Maira T Barbosa; Karoline C Carmona; Henrique C Guimarães; Maria G Carvalho; Ana P Fernandes; Karina B Gomes
Journal:  J Clin Lab Anal       Date:  2015-08-24       Impact factor: 2.352

10.  Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease.

Authors:  Ling Li; Dongfeng Cao; Renee Desmond; Atiq Rahman; James J Lah; Allan I Levey; Edward Zamrini
Journal:  Dement Geriatr Cogn Disord       Date:  2008-10-16       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.